Therapy News and Research

RSS
Study helps identify optimal treatment option for NSCLC patients with brain metastases

Study helps identify optimal treatment option for NSCLC patients with brain metastases

BREXIT vote threatens to disrupt advances in gene and cell therapies in the UK

BREXIT vote threatens to disrupt advances in gene and cell therapies in the UK

Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

Radiation boost provides added benefit to DCIS patients following breast-conserving surgery and WBRT

Researchers link RHOX gene mutations to infertility in men

Researchers link RHOX gene mutations to infertility in men

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

Early endovascular thrombectomy plus medical therapy linked to less disability after stroke

Early endovascular thrombectomy plus medical therapy linked to less disability after stroke

New study highlights clinical and economic burden of NAFLD in the U.S. and Europe

New study highlights clinical and economic burden of NAFLD in the U.S. and Europe

Combination of different drugs could improve effect of immunotherapy on skin cancer

Combination of different drugs could improve effect of immunotherapy on skin cancer

New project clarifies molecular processes involved in hidden HIV reservoir

New project clarifies molecular processes involved in hidden HIV reservoir

Expectations of cancer patients may not match with actual results in phase I studies

Expectations of cancer patients may not match with actual results in phase I studies

Super-Resolution Imaging of Biological Specimens

Super-Resolution Imaging of Biological Specimens

Researchers identify process in the brains of mice that may explain repetitive actions in Rett patients

Researchers identify process in the brains of mice that may explain repetitive actions in Rett patients

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

New ABT approach results in greater weight loss than gold standard treatment, study shows

New ABT approach results in greater weight loss than gold standard treatment, study shows

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Endocrine Society Clinical Practice Guideline recommends CGMs for Type 1 diabetes patients

Endocrine Society Clinical Practice Guideline recommends CGMs for Type 1 diabetes patients

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

UCM REACT program receives $2 million federal grant to support children affected by violence

UCM REACT program receives $2 million federal grant to support children affected by violence

CNS experts create new research-based guidelines for evaluation and treatment of NFPAs

CNS experts create new research-based guidelines for evaluation and treatment of NFPAs

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.